![](/img/cover-not-exists.png)
Antiretroviral Activity, Pharmacokinetics, and Tolerability of MK-0518, a Novel Inhibitor of HIV-1 Integrase, Dosed As Monotherapy for 10 Days in Treatment-Naive HIV-1-Infected Individuals
Markowitz, Martin, Morales-Ramirez, Javier O, Nguyen, Bach-Yen, Kovacs, Colin M, Steigbigel, Roy T, Cooper, David A, Liporace, Ralph, Schwartz, Robert, Isaacs, Robin, Gilde, Lucinda R, Wenning, LarissVolume:
43
Language:
english
Journal:
JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI:
10.1097/qai.0b013e31802b4956
Date:
December, 2006
File:
PDF, 243 KB
english, 2006